Log in

ASX:NOXNoxopharm Stock Price, Forecast & News

0.00 (0.00 %)
(As of 05/13/2020)
Today's Range
Now: A$0.19
50-Day Range
MA: A$0.19
52-Week Range
Now: A$0.19
Volume1.23 million shs
Average VolumeN/A
Market Capitalization$31.90 million
P/E RatioN/A
Dividend YieldN/A
Noxopharm Limited, a drug development company, focuses on the research and development of drugs to enhance radiotherapy in Australia and internationally. It is developing Veyonda, a dosage formulation of idronoxil, a generic anti-cancer agent for the treatment of late-stage cancers. The company also focuses on developing NYX-104, a drug intended to protect the brain from excitotoxicity; NYX-205, a drug to treat inflammation of the nervous tissue; and NYX-330, a PCSK9-inhibitor developed as a companion product for statin drugs in lowering low density lipoprotein cholesterol levels in patients at risk of cardiovascular disease. Noxopharm Limited was incorporated in 2015 and is based in Gordon, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.44 out of 5 stars

Industry, Sector and Symbol

Industry Biotechnology
Phone61 2 9144 2223



Sales & Book Value

Annual Sales$4.25 million
Cash FlowA$0.01 per share
Book ValueA($0.03) per share



Market Cap$31.90 million
Next Earnings DateN/A
OptionableNot Optionable

Receive NOX News and Ratings via Email

Sign-up to receive the latest news and ratings for NOX and its competitors with MarketBeat's FREE daily newsletter.

Noxopharm (ASX:NOX) Frequently Asked Questions

How has Noxopharm's stock been impacted by COVID-19 (Coronavirus)?

Noxopharm's stock was trading at A$0.17 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NOX shares have increased by 8.8% and is now trading at A$0.19. View which stocks have been most impacted by Coronavirus.

How were Noxopharm's earnings last quarter?

Noxopharm Ltd (ASX:NOX) posted its quarterly earnings data on Thursday, February, 21st. The company reported ($0.04) earnings per share for the quarter. View Noxopharm's earnings history.

Has Noxopharm been receiving favorable news coverage?

Press coverage about NOX stock has trended extremely negative on Saturday, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Noxopharm earned a media sentiment score of -4.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news aboutNoxopharm.

Who are some of Noxopharm's key competitors?

What other stocks do shareholders of Noxopharm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Noxopharm investors own include Venture Minerals (VMS), Paradigm Biopharmaceuticals (PAR), Lincoln Educational Services (LINC), IMMURON LTD/S (IMRN), Avita Medical (AVH) and Afterpay Touch Group (APT).

Who are Noxopharm's key executives?

Noxopharm's management team includes the following people:
  • Dr. Graham Edmund Kelly, Group CEO, MD & Director (Age 74)
  • Mr. David James Franks B.Ec, BEc, CA, F Fin, JP., Company Sec. (Age 49)
  • Dr. Greg van Wyk, CEO & Chief Medical Officer
  • Mr. Bhavin Raval, Chief Financial Officer
  • Dr. John Wilkinson, Chief Scientific Officer

What is Noxopharm's stock symbol?

Noxopharm trades on the ASX under the ticker symbol "NOX."

What is Noxopharm's stock price today?

One share of NOX stock can currently be purchased for approximately A$0.19.

How big of a company is Noxopharm?

Noxopharm has a market capitalization of $31.90 million and generates $4.25 million in revenue each year.

What is Noxopharm's official website?

The official website for Noxopharm is www.noxopharm.com.

How can I contact Noxopharm?

The company can be reached via phone at 61 2 9144 2223.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.